Minneapolis, MN, United States of America

Miles Kealy

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boston Scientific Scimed, Inc.. Active years: 2024.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Miles Kealy

Introduction

Miles Kealy is an innovative inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical devices, particularly in the treatment of pancreatic cancer. His work focuses on developing systems and methods that utilize electric fields to target cancerous tumors effectively.

Latest Patents

Miles Kealy holds a patent for "Systems and methods for treatment of pancreatic cancer." This patent describes a medical device system that includes an electric field generating circuit designed to produce one or more electric fields. The system is equipped with control circuitry and electrodes on stimulation leads that deliver electric fields directly to the site of a cancerous tumor within a patient. The design allows for implantation near the duodenum, with the electric fields generated at frequencies ranging from 10 kHz to 1 MHz. This innovative approach aims to enhance the effectiveness of cancer treatment.

Career Highlights

Miles Kealy is associated with Boston Scientific Scimed, Inc., where he continues to work on advancing medical technology. His dedication to improving cancer treatment through innovative solutions has positioned him as a notable figure in the medical device industry.

Collaborations

Miles collaborates with talented professionals such as Kyle Harish Srivastava and Vijay Koya. Their combined expertise contributes to the development of cutting-edge medical technologies.

Conclusion

Miles Kealy's work in the field of medical devices represents a significant advancement in the treatment of pancreatic cancer. His innovative patent showcases the potential of electric field technology in targeting cancerous tumors, paving the way for future developments in cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…